Randomized Multicenter Trial Assessing if Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Will Change Primary Treatment
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Breast Neoplasm
- Sponsor
- Karolinska University Hospital
- Enrollment
- 440
- Locations
- 1
- Primary Endpoint
- Change of treatment plan
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
The study is a prospective randomised multicenter trial assessing the additional value of breast MRI in women under 56 years of age with newly diagnosed breast cancer. Will preoperative breast MRI change treatment regimen? Will preoperative breast MRI reduce the number of primary surgeries? Will preoperative breast MRI increase the rate of mastectomies? Will preoperative breast MRI be cost effective?
Detailed Description
Completed: the study has concluded normally; participants are no longer being examined or treated (i.e., last patient's last visit has occurred)
Investigators
Brita Arver
MD, PhD
Karolinska University Hospital
Eligibility Criteria
Inclusion Criteria
- •Women under 56 years of age
- •Newly diagnosed breast cancer
- •Swedish or English speaking
Exclusion Criteria
- •Claustrophobia
- •Pregnancy
- •Renal failure
- •Metal items in patients
Outcomes
Primary Outcomes
Change of treatment plan
Time Frame: 14 days
Did breast magnetic resonance imaging add information about the tumour that changed primary treatment plan
Secondary Outcomes
- Did breast magnetic resonance imaging reduce the number of reoperation during primary management(6 months)
- Did breast magnetic resonance imaging increase the number of mastectomies(6 months)
- Did breast magnetic resonance imaging affect cost(6 months)